Malignant mesothelioma is a tough cancer to treat. Even with a short survival time, some people with this cancer live longer than expected. A recent study in a science journal called Toxics looked at patients with mesothelioma and asbestos-related lung cancer. All of them had been around asbestos between 2009[…]
Full Archive
Machine Learning Can Help Predict Outcomes for Peritoneal Mesothelioma
Cancer treatment is complex. Doctors need to estimate how long patients might live to choose the best treatments. New technologies like machine learning and deep learning have improved this process. These technologies are especially good at predicting how long cancer patients might survive. A new study focuses on a rare[…]
Using Technology to Understand the Genetics of Mesothelioma
A new study used advanced technology to understand the genetic details of mesothelioma. New results are pointing to potential ways to personalize treatment for this rare and aggressive cancer. Mesothelioma is a cancer of the thin membrane that surrounds different organs and areas of the body. It is caused by[…]
3D Printing and Optical Scanning Could Help Mesothelioma Treatment
New technologies offer hope for more effective treatments for malignant pleural mesothelioma and other hard-to-treat cancers. One innovation is the use of 3D printing and optical scanning. These new technologies refine photodynamic therapy, a promising approach for mesothelioma management. Photodynamic therapy uses the power of light to target and destroy[…]
Ipilimumab and Nivolumab Can Improve Survival in Mesothelioma Patients
Mesothelioma is a rare and tough cancer to treat and is usually linked to asbestos exposure. Scientists are continually exploring new ways to treat it, and one promising method is using the combination of the two drugs nivolumab and ipilimumab. A new study looks at what these drugs do and[…]
Mesothelin Could Be Used to Improve Mesothelioma Treatment
Mesothelioma is a hard cancer to treat and understand. Understanding protein expressed by mesothelioma cells could potentially help. This protein may be a clue to the cancer, but an easier way to check for it in a lab needs to be found. In the study, scientists dig into mesothelin, see[…]
Radiomics Can Be Used to Improve Mesothelioma Treatment
Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Identifying which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]
Recurring Collapsed Lung Could Indicate Mesothelioma
A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly due to its long latency period. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old man whose recurrent[…]
A Type of T Cell Therapy is Showing Promising Results for Mesothelioma
A clinical trial testing a new type of cell therapy for mesothelioma is actively recruiting patients at sites across the country, including Moffitt Cancer Center in Tampa, Florida. The trial is early stage. The therapy, called Synkir-110, is a lab-engineered cell treatment designed to target mesothelin, a protein found on[…]
A New Guideline for Surgery has Been Created for Mesothelioma
A national panel of 15 mesothelioma specialists across surgery, medical oncology, radiation oncology, and pathology reached a consensus and issued new guidelines for surgery. The experts reviewed 116 studies and data from 630 mesothelioma surgeries between 2015 and 2025. After three rounds of formal voting, the panel challenged reluctance to[…]
Skip to content